Silvoniemi Antti, Pulkkinen Jaakko, Grénman Reidar
Department of Otorhinolaryngology–Head and Neck Surgery, Turku University Hospital, University of Turku, Finland.
Acta Otolaryngol. 2010 Nov;130(11):1300-5. doi: 10.3109/00016489.2010.488248.
Parotidectomy is an efficient surgical treatment modality for pleomorphic adenoma of the parotid gland, although some morbidity may occur. In this study, the median time interval between primary surgery and the presentation of the recurrent tumor was observed to be 14.4 years.
Analysis of the long-term results of patients undergoing lateral or total parotidectomy as first-line treatment of parotid pleomorphic adenoma at our institution between the years 1979 and 1996.
The individual patient charts of 230 patients were feasible for retrospective analysis in 2007.
In all, 42 patients had dysfunction of the facial nerve after the primary surgery, but only 14 of them had permanent dysfunction. A recurrent tumor occurred in nine cases (3.9%). The time interval between primary surgery and the first recurrence ranged from 7.1 to 24.5 years. Recurrent tumors were treated with surgery, two patients received additional radiotherapy.
腮腺切除术是治疗腮腺多形性腺瘤的一种有效手术方式,尽管可能会出现一些并发症。在本研究中,观察到初次手术与复发性肿瘤出现之间的中位时间间隔为14.4年。
分析1979年至1996年间在我院接受外侧或全腮腺切除术作为腮腺多形性腺瘤一线治疗的患者的长期结果。
2007年对230例患者的个人病历进行回顾性分析。
总共42例患者在初次手术后出现面神经功能障碍,但其中只有14例有永久性功能障碍。9例(3.9%)出现复发性肿瘤。初次手术与首次复发之间的时间间隔为7.1至24.5年。复发性肿瘤采用手术治疗,2例患者接受了额外的放疗。